This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ahmed, S. F. Articles by James, S. L. Search for Related Content PubMed PubMed Citation Articles by Ahmed, S. F. Articles by James, S. L.

 Previous Article  |  Next Article 

Infect. Immun., 01 1997, 219-226, Vol 65, No. 1
Copyright © 1997, American Society for Microbiology

Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni

SF Ahmed, IP Oswald, P Caspar, S Hieny, L Keefer, A Sher and SL James
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

A persistent paradox in our understanding of protective immunity against Schistosoma mansoni infection in animals vaccinated with attenuated parasites has been that attrition of challenge parasites occurs during migration through the lungs in vivo, although parasites recovered from the lungs appear to be relatively resistant to cytotoxic effector mechanisms in vitro. We have compared the susceptibilities of different stages of larvae to killing by nitric oxide (NO), which was previously shown to be involved in the larvicidal function of cytokine- activated cytotoxic effector cells. Lung-stage larvae obtained 1 week after infection were not killed in vitro by NO generated either by a chemical NO donor or by activated cells. In contrast, parasites obtained from the portal system of control mice or from the lungs of vaccinated mice 2.5 weeks following challenge infection were killed by NO. As previously shown for mammalian cell targets, the effects of NO in susceptible larval stages may involve enzymes required for aerobic energy metabolism, since similar cytotoxicity was demonstrated by chemical inhibitors of the citric acid cycle or mitochondrial respiration. Taken together with previous observations of enhanced Th1 activity and expression of NO synthase in the lungs of vaccinated mice at 2.5 weeks after challenge infection, these observations elucidate the immune mechanism of vaccine-induced resistance to S. mansoni infection. Moreover, they suggest that conversion to a less metabolically active state may allow pathogens to escape the effects of the important effector molecule NO.

This article has been cited by other articles:

• Cook, R. M., Carvalho-Queiroz, C., Wilding, G., LoVerde, P. T. (2004). Nucleic Acid Vaccination with Schistosoma mansoni Antioxidant Enzyme Cytosolic Superoxide Dismutase and the Structural Protein Filamin Confers Protection against the Adult Worm Stage. Infect. Immun. 72: 6112-6124 [Abstract] [Full Text]  
• Rodriguez-Sosa, M., Saavedra, R., Tenorio, E. P., Rosas, L. E., Satoskar, A. R., Terrazas, L. I. (2004). A STAT4-Dependent Th1 Response Is Required for Resistance to the Helminth Parasite Taenia crassiceps. Infect. Immun. 72: 4552-4560 [Abstract] [Full Text]  
• Rodriguez-Sosa, M., Rosas, L. E., David, J. R., Bojalil, R., Satoskar, A. R., Terrazas, L. I. (2003). Macrophage Migration Inhibitory Factor Plays a Critical Role in Mediating Protection against the Helminth Parasite Taenia crassiceps. Infect. Immun. 71: 1247-1254 [Abstract] [Full Text]  
• Rodriguez-Sosa, M., David, J. R., Bojalil, R., Satoskar, A. R., Terrazas, L. I. (2002). Cutting Edge: Susceptibility to the Larval Stage of the Helminth Parasite Taenia crassiceps Is Mediated by Th2 Response Induced Via STAT6 Signaling. J. Immunol. 168: 3135-3139 [Abstract] [Full Text]  
• Street, M., Coulson, P. S., Sadler, C., Warnock, L. J., McLaughlin, D., Bluethmann, H., Wilson, R. A. (1999). TNF Is Essential for the Cell-Mediated Protective Immunity Induced by the Radiation-Attenuated Schistosome Vaccine. J. Immunol. 163: 4489-4494 [Abstract] [Full Text]  
• James, S. L., Cheever, A. W., Caspar, P., Wynn, T. A. (1998). Inducible Nitric Oxide Synthase-Deficient Mice Develop Enhanced Type 1 Cytokine-Associated Cellular and Humoral Immune Responses after Vaccination with Attenuated Schistosoma mansoni Cercariae but Display Partially Reduced Resistance. Infect. Immun. 66: 3510-3518 [Abstract] [Full Text]